Dipharma expands its Italian R&D Center to increase its analytical services
The Company strengthens its analytical R&D capabilities, to better support its customers operating in the CDMO and Generics market.
The Company strengthens its analytical R&D capabilities, to better support its customers operating in the CDMO and Generics market.
The Company continues to strengthen its capabilities in the North American market
Thanks to the approval by the Italian Medicines Agency (AIFA), the Company increases its efficiency and is able to face the growing demand for its services